CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE
Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas… Read More
Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas… Read More
Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of… Read More
Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from… Read More
Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes,… Read More
Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs… Read More
Commends Bipartisan Collaboration on Several Market-Based Solutions… Read More
Looks Forward to Working With Senate Finance Members to Hold Big Pharma… Read More
Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American… Read More
Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019… Read More
Greater List Price Transparency Will Help Hold Big Pharma Accountable… Read More
Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability… Read More
Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors… Read More